Alexander D. Douglas

Active 2011–2025

Also published as
Alexander D Douglas
47
Papers
18,333
Citations
37
h-index
45
i10-index

Citations

Citations per year for Alexander D. Douglas1974: 1 citations1987: 1 citations2002: 1 citations2003: 1 citations2005: 1 citations2011: 4 citations2012: 16 citations2013: 43 citations2014: 48 citations2015: 89 citations2016: 67 citations2017: 72 citations2018: 45 citations2019: 148 citations2020: 564 citations2021: 3,430 citations2022: 1,852 citations2023: 545 citations2024: 566 citations2025: 140 citations2026: 4 citations1975–1986: no citations, so these years are not shown1988–2001: no citations, so these years are not shown2004: no citations, so this year is not shown2006–2010: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,656 citing papers, 18.7% of this breakdownUnited Kingdom: 1,076 citing papers, 12.1% of this breakdownChina: 533 citing papers, 6% of this breakdownGermany: 396 citing papers, 4.5% of this breakdownIndia: 328 citing papers, 3.7% of this breakdownItaly: 326 citing papers, 3.7% of this breakdownAustralia: 318 citing papers, 3.6% of this breakdownCanada: 271 citing papers, 3.1% of this breakdownFrance: 257 citing papers, 2.9% of this breakdownNetherlands: 215 citing papers, 2.4% of this breakdownSpain: 180 citing papers, 2% of this breakdownSwitzerland: 164 citing papers, 1.8% of this breakdown
0%18.7%Other 35.5%

Fields

  • Medicine78.9%
  • Biochemistry, Genetics and Molecular Biology6.3%
  • Immunology and Microbiology4%
  • Social Sciences3.4%
  • Mathematics2.1%
  • Engineering0.8%
  • Other4.5%

Topics

  • SARS-CoV-2 and COVID-19 Research23.7%
  • COVID-19 Clinical Research Studies10.9%
  • Vaccine Coverage and Hesitancy6.4%
  • vaccines and immunoinformatics approaches3.9%
  • COVID-19 epidemiological studies2.9%
  • Animal Virus Infections Studies2.8%
  • Other49.4%

Coauthors

All papers

Open in search
  1. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Hill, Helen Hill, Ian Hirsch, Susanne H. Hodgson, Alane Izu, Susan Jackson, Daniel Jenkin, Carina C. D. Joe, Simon Kerridge, Anthonet Koen, Gaurav Kwatra, Rajeka Lazarus, Alison M. Lawrie, Alice Lelliott, Vincenzo Libri, Patrick Lillie, Raburn M. Mallory, Ana Verena Almeida Mendes, Eveline Pı́polo Milan, Angela M. Minassian, Alastair McGregor, Hazel Morrison, Yama F Mujadidi, Anusha Nana, Peter O’Reilly, Sherman D. Padayachee, Ana Maria Pittella, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Sarah Rhead, Alexandre Vargas Schwarzbold, Nisha Singh, Darren Smith, Rinn Song, Matthew D. Snape, Eduardo Sprinz, Rebecca Sutherland, Richard Tarrant, Emma C. Thomson, M. Estée Török, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Marion Watson, Christopher J. Williams, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, Marites Aban, Fatola Abayomi, Kushala W.M. Abeyskera, Jeremy Aboagye, Matthew Adam, Kirsty Adams, James P. Adamson, Yemi Adelaja, Gbadebo Adewetan, Syed Adlou, Khatija Ahmed, Yasmeen Akhalwaya, Saajida Akhalwaya, Andrew Alcock, Aabidah Ali, Elizabeth Allen, Lauren Allen, Thamires C. D. S. C Almeida and 665 more - The Lancet 2020 cited by 5,010

  2. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah C. Gilbert, Andrew J. Pollard, Jeremy Aboagye, K. F. Adams, Aabidah Ali, Elizabeth Allen, Jennifer L. Allison, Rachel Anslow, Edward H. Arbe-Barnes, Gavin Babbage, J. Kenneth Baillie, Megan Baker, Natalie Baker, Philip Baker, Ioana Baleanu, Juliana Ballaminut, Eleanor Barnes, Jordan R. Barrett, Louise Bates, Alexander Batten, Kirsten Beadon, Rebecca Beckley, Eleanor Berrie, Lisa Berry, Amy Beveridge, Kevin R. Bewley, Else M. Bijker, Tracey Bingham, Luke Blackwell, Caitlin L. Blundell, Emma Bolam, Elena Boland, Nicola Borthwick, Thomas Bower, Amy Boyd, Tanja Brenner, Philip Bright, Charlie Brown-O’Sullivan, Emily Brunt, Jamie Burbage, Sharon Burge, Karen R. Buttigieg, Nicholas Byard, Ingrid Cabera Puig, Anna Calvert, Susana Camara, Michelangelo Cao, Federica Cappuccini, Melanie Carr, Miles W. Carroll, Victoria Carter, Katrina Cathie, Ruth Challis, Sue Charlton, Irina Chelysheva, Jee-Sun Cho, Paola Cicconi, Liliana Cifuentes, Helen Clark, Elizabeth Clark, Tom Cole, Rachel Colin-Jones, Christopher P. Conlon, Aislinn Cook, Naomi S. Coombes, Rachel Cooper, Catherine A. Cosgrove, Karen Coy, Wendy E.M. Crocker, Christina J. Cunningham and 265 more - The Lancet 2020 cited by 2,614

  3. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amy Beveridge, Kevin R. Bewley, Phillip J. Brown, Emily Brunt, Karen R. Buttigieg, Susana Camara, Sue Charlton, Emily Chiplin, Paola Cicconi, Elizabeth Clutterbuck, Andrea M. Collins, Naomi S. Coombes, Sue Ann Costa Clemens, M. Davison, Tesfaye Demissie, Tanya Dinesh, Alexander D. Douglas, C.J. Duncan, Katherine R. W. Emary, Katie Ewer, Sally Felle, Daniela M. Ferreira, Adam Finn, Pedro M. Folegatti, Ross Fothergill, Sara Fraser, Harriet Garlant, Laura Gatcombe, Kerry Godwin, Anna L. Goodman, Christopher Green, Bassam Hallis, Thomas C. Hart, Paul T. Heath, Helen Hill, Adrian V. S. Hill, Daniel Jenkin, Mwila Kasanyinga, Simon Kerridge, Chanice Knight, Stephanie Leung, Vincenzo Libri, Patrick Lillie, Spyridoula Marinou, Joanna McGlashan, Alastair McGregor, Lorna McInroy, Angela M. Minassian, Yama F Mujadidi, Elizabeth J. Penn, Christos J. Petropoulos, Katrina M. Pollock, Pamela C. Proud, Samuel Provstgaard-Morys, Durga Rajapaska, Maheshi Ramasamy, Katherine Sanders, Imam H. Shaik, Nisha Singh, Andrew Smith, Matthew D. Snape, Rinn Song, Sonu Shrestha, Rebecca Sutherland, Emma C. Thomson, David P. J. Turner, Alice Webb-Bridges, Terri Wrin, Christopher J. Williams - Nature Medicine 2021 cited by 1,239

  4. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Green, Christopher Green, Melanie Greenland, Catherine Hill, Helen Hill, Ian Hirsch, Alane Izu, Daniel Jenkin, Carina C. D. Joe, Simon Kerridge, Anthonet Koen, Gaurav Kwatra, Rajeka Lazarus, Vincenzo Libri, Patrick Lillie, Natalie G. Marchevsky, Richard P. Marshall, Ana Verena Almeida Mendes, Eveline Pı́polo Milan, Angela M. Minassian, Alastair McGregor, Yama F Mujadidi, Anusha Nana, Sherman D. Padayachee, Daniel J. Phillips, Ana Maria Pittella, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Adam Ritchie, Hannah Robinson, Alexandre Vargas Schwarzbold, Darren Smith, Rinn Song, Matthew D. Snape, Eduardo Sprinz, Rebecca Sutherland, Emma C. Thomson, M. Estée Török, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Thomas White, Christopher J. Williams, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, Marites Aban, Kushala W.M. Abeyskera, Jeremy Aboagye, Matthew Adam, Kirsty Adams, James P. Adamson, Gbadebo Adewatan, Syed Adlou, Khatija Ahmed, Yasmeen Akhalwaya, Saajida Akhalwaya, Andrew Alcock, Aabidah Ali, Elizabeth Allen, Lauren Allen, Felipe B. Alvernaz, Fabio Santos Amorim, Claudia Sala Andrade, Foteini Andritsou, Rachel Anslow and 666 more - The Lancet 2021 cited by 1,208

  5. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - EBioMedicine 2022 cited by 146

  6. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth J Kelly, Simon Kerridge, Alison M Lawrie, Alice Lelliott, May N Lwin, Rebecca Makinson, Natalie G Marchevsky, Yama Mujadidi, Alasdair P S Munro, Mihaela Pacurar, Emma Plested, Jade Rand, Thomas Rawlinson, Sarah Rhead, Hannah Robinson, Adam J Ritchie, Amy L Ross-Russell, Stephen Saich, Nisha Singh, Catherine C Smith, Matthew D Snape, Rinn Song, Richard Tarrant, Yrene Themistocleous, Kelly M Thomas, Tonya L Villafana, Sarah C Warren, Marion E E Watson, Alexander D Douglas, Adrian V S Hill, Teresa Lambe, Sarah C Gilbert, Saul N Faust, Andrew J Pollard, Jeremy Aboagye, Kelly Adams, Aabidah Ali, Elizabeth R. Allen, Lauren Allen, Jennifer L. Allison, Foteini Andritsou, Rachel Anslow, Edward H. Arbe-Barnes, Megan Baker, Natalie Baker, Philip Baker, Ioana Baleanu, Debbie Barker, Eleanor Barnes, Jordan R. Barrett, Kelly Barrett, Louise Bates, Alexander Batten, Kirsten Beadon, Rebecca Beckley, Duncan Bellamy, Adam Berg, Laura Bermejo, Eleanor Berrie, Amy Beveridge, Kevin Bewley, Else M. Bijker, Geeta Birch, Luke Blackwell, Heather Bletchly, Caitlin L. Blundell, Susannah R. Blundell, Emma Bolam, Elena Boland, Daan Bormans and 321 more - The Lancet 2020 cited by 1,405

  7. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Moore, Yama F Mujadidi, Emma Plested, Ian Poulton, Maheshi Ramasamy, Hannah Robinson, Rinn Song, Matthew D. Snape, Richard Tarrant, Merryn Voysey, Marion Watson, Alexander D. Douglas, Adrian V. S. Hill, Sarah C. Gilbert, Andrew J. Pollard, Teresa Lambe, the Oxford COVID Vaccine Trial Group, Aabidah Ali, Elizabeth Allen, Megan Baker, Eleanor Barnes, Nicola Borthwick, Amy Boyd, Charlie Brown-O’Sullivan, Joshua Burgoyne, Nicholas Byard, Ingrid Cabrera Puig, Federica Cappuccini, Jee-Sun Cho, Paola Cicconi, Elizabeth Clark, Wendy E.M. Crocker, Mehreen S. Datoo, H. Dele Davies, Francesca R. Donnellan, Susanna Dunachie, Nick J. Edwards, Sean C. Elias, Julie Furze, Ciarán Gilbride, Giacomo Gorini, Gaurav Gupta, Stephanie A. Harris, Susanne H. Hodgson, Mimi M. Hou, Susan Jackson, Kathryn Jones, Reshma Kailath, Lloyd D. W. King, Colin W. Larkworthy, Yuanyuan Li, Amelia M. Lias, Aline Linder, Samuel Lipworth, Raquel Lopez Ramon, Meera Madhavan, Emma Marlow, Julia L. Marshall, Alexander J. Mentzer, Hazel Morrison, Nathifa Moya, Ekta Mukhopadhyay, Andrés Noé, Fay L. Nugent, Dimitra Pipini, David Pulido-Gomez, Fernando Ramos Lopez, Adam Ritchie, Indra Rudiansyah, Stephannie Salvador and 184 more - Nature Medicine 2020 cited by 643

  8. Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Silman, Mehreen Datoo, Iona J. Taylor, Jing Jin, David Pulido, Alexander D. Douglas, Willem A. de Jongh, Robert Smith, Eleanor Berrie, Amy R. Noe, Carter L. Diggs, Lorraine Soisson, Rebecca Ashfield, Saul N. Faust, Anna L. Goodman, Alison M. Lawrie, Fay L. Nugent, Galit Alter, Carole A. Long, Simon J. Draper - Med 2021 cited by 167

  9. A PfRH5-Based Vaccine Is Efficacious against Heterologous Strain Blood-Stage Plasmodium falciparum Infection in Aotus Monkeys

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2015 cited by 238

  10. Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew K. Higgins, Simon J. Draper - Cell 2019 cited by 176

  11. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bassam Hallis, Paul T. Heath, Jodie Hay, Helen Hill, Daniel Jenkin, Simon Kerridge, Rajeka Lazarus, Vincenzo Libri, Patrick Lillie, Catherine Ludden, Natalie G. Marchevsky, Angela M. Minassian, Alastair McGregor, Yama F Mujadidi, Daniel J. Phillips, Emma Plested, Katrina M. Pollock, Hannah Robinson, Darren Smith, Rinn Song, Matthew D. Snape, Rebecca Sutherland, Emma C. Thomson, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Christopher J. Williams, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Merryn Voysey, Maheshi Ramasamy, Andrew J. Pollard - The Lancet 2021 cited by 651

  12. Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies

    Authors: , , , , , , , , , , , - Nature 2014 cited by 236

  13. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2011 cited by 292

  14. A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates

    Authors: , , , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 78

  15. Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angela M. Minassian, Rebecca Ashfield, Nicola K. Viebig, Fay L. Nugent, Alexander D. Douglas, Johan Vekemans, Gavin J. Wright, Saul N. Faust, Adrian V. S. Hill, Carole A. Long, Alison M. Lawrie, Simon J. Draper - JCI Insight 2017 cited by 153

  16. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rebecca Makinson, Jack Mellors, Angela M. Minassian, Maria Moore, Yama F Mujadidi, Emma Plested, Ian Poulton, Maheshi Ramasamy, Hannah Robinson, Christine S. Rollier, Rinn Song, Matthew D. Snape, Richard Tarrant, Stephen Taylor, Kelly Thomas, Merryn Voysey, Marion Watson, Daniel Wright, Alexander D. Douglas, Catherine Green, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, the Oxford COVID Vaccine Trial Group, Jeremy Aboagye, Jennifer Alderson, Aabidah Ali, Elizabeth Allen, Lauren Allen, Rachel Anslow, Carolina V. Arancibia-Cárcamo, Edward H. Arbe-Barnes, Megan Baker, Philip Baker, Natalie Baker, Ioana Baleanu, Eleanor Barnes, Louise Bates, Alexander Batten, Kirsten Beadon, Rebecca Beckley, Amy Beveridge, Kevin R. Bewley, Else M. Bijker, Luke Blackwell, Caitlin L. Blundell, Emma Bolam, Elena Boland, Nicola Borthwick, Amy Boyd, Tanja Brenner, Philip N. Brown, Charlie Brown-O’Sullivan, Emily Brunt, Jamie Burbage, Karen R. Buttigieg, Nicholas Byard, Ingrid Cabrera Puig, Susana Camara, Michelangelo Cao, Federica Cappuccini, Melanie Carr, Miles W. Carroll, Jim Chadwick, Irina Chelysheva, Jee-Sun Cho, Liliana Cifuentes, Elizabeth Clark, Rachel Colin-Jones and 203 more - Nature Medicine 2020 cited by 340

  17. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rinn Song, Danielle Woods, Gavin Screaton, Sarah C. Gilbert, Merryn Voysey, Andrew J. Pollard, Teresa Lambe, Syed Adlou, Robert Aley, Aabidah Ali, Rachel Anslow, Megan Baker, Phillip Baker, Jordan R. Barrett, Louise Bates, Kirsten Beadon, Rebecca Beckley, Jonathan Bell, Duncan Bellamy, Amy Beveridge, Cameron Bissett, Luke Blackwell, Heather Bletchly, Amy Boyd, Alice Bridges-Webb, Charlie Brown, Nicholas Byard, Susana Camara, Liliana Cifuentes Gutierrez, Andrea M. Collins, Rachel Cooper, Wendy E.M. Crocker, Thomas C. Darton, H. Dele Davies, J Davies, Tesfaye Demissie, Claudio Di Maso, Tanya Dinesh, Francesca R. Donnellan, Alexander D. Douglas, Rachael Drake-Brockman, C.J. Duncan, Sean C. Elias, Katherine R. W. Emary, Mutjaba Farooq, Saul N. Faust, Sally Felle, Daniela M. Ferreira, Carla Ferreira Da Silva, Adam Finn, Karen Ford, Emma Francis, Julie Furze, Michelle Fuskova, Eva Galiza, Ana Gibertoni Cruz, Leila Godfrey, Anna L. Goodman, Catherine Green, Christopher Green, Nicola M. Greenwood, Daisy Harrison, Thomas C. Hart, Sophia Hawkins, Paul T. Heath, Helen Hill, Kushalinii Hillson, Bryn Horsington, Mimi M. Hou, Elizabeth Howe and 87 more - The Lancet 2021 cited by 258

  18. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hanna Nguyen, Lucia Parolini, Claire Petersen, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Sarah Rhead, Hannah Robinson, Nicola Robinson, Patpong Rongkard, Fiona Ryan, Sonia Serrano, Timothy Tipoe, Merryn Voysey, Anele Waters, Panagiota Zacharopoulou, Eleanor Barnes, Susanna Dunachie, Philip Goulder, Paul Klenerman, Gavin Screaton, Alan Winston, Adrian V. S. Hill, Sarah C. Gilbert, Andrew J. Pollard, Sarah Fidler, Julie Fox, Teresa Lambe, Marion Watson, Rinn Song, Paola Cicconi, Angela M. Minassian, Sagida Bibi, Simon Kerridge, Nisha Singh, Catherine Green, Alexander D. Douglas, Alison M. Lawrie, Elizabeth Clutterbuck - The Lancet HIV 2021 cited by 256

  19. Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rebecca Ashfield, Simon J. Draper - npj Vaccines 2018 cited by 82

  20. Neutralization of Plasmodium falciparum Merozoites by Antibodies against PfRH5

    Authors: , , , , , , , , , , , , , , , , , - The Journal of Immunology 2013 cited by 156

  21. Enhancing Blockade of Plasmodium falciparum Erythrocyte Invasion: Assessing Combinations of Antibodies against PfRH5 and Other Merozoite Antigens

    Authors: , , , , , , , , , , , , , , - PLoS Pathogens 2012 cited by 139

  22. Structure of trimeric pre-fusion rabies virus glycoprotein in complex with two protective antibodies

    Authors: , , , , , , , , , - Cell Host & Microbe 2022 cited by 64

  23. Demonstration of the Blood-StagePlasmodium falciparumControlled Human Malaria Infection Model to Assess Efficacy of theP. falciparumApical Membrane Antigen 1 Vaccine, FMP2.1/AS01

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James McCarthy, Carter L. Diggs, Johan Vekemans, Carole A. Long, Adrian V. S. Hill, Alison M. Lawrie, Sheetij Dutta, Simon J. Draper - The Journal of Infectious Diseases 2016 cited by 115

  24. Manufacturing a chimpanzee adenovirus‐vectored SARS‐CoV‐2 vaccine to meet global needs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raghavan Venkat, Adam Ritchie, Sarah C. Gilbert, Richard Turner, Alexander D. Douglas - Biotechnology and Bioengineering 2021 cited by 67